The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
Hypoxia-responsive nanoparticle based drug delivery systems in cancer therapy: An up-to-date review
Abstract
Hypoxia is a salient feature observed in most solid malignancies that holds a pivotal role in angiogenesis, metastasis and resistance to conventional cancer therapeutic approaches, and thus enables cancer progression. However, the typical characteristics of hypoxic cells such as low oxygen levels and highly bio-reductive environment can offer stimuli-responsive drug release to aid in tumor-specific chemo, radio, photodyanamic and sonodynamic therapies. This approach based on targeting the poorly oxygenated tumor habitats offers the prospective to overcome the difficulties that arises due to heterogenic nature of tumor and could be possibly used in the design of diagnostic as well as therapeutic nanocarriers for targeting various types of solid cancers. Consequently, hypoxia triggered nanoparticle based drug delivery systems is a rapidly progressing research area in developing effective strategies to combat drug-resistance in solid tumors. The present review presents the recent advances in the development of hypoxia-responsive nanovehicles for drug delivery to heterogeneous tumors. The initial sections of the article provides insights into the development of hypoxia in growing cancer and its role in disease progression. The current limitations and the future prospective of hypoxia-stimulated nanomachines for cancer treatment are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–226 of 226
Mao, C., Livezey, M. R., Kim, J. E., & Shapiro, D. J. (2016) · Scientific Reports · doi:10.1038/srep34753 · Cited by 63
Klevebring, D., Rosin, G., Ma, R., Lindberg, J., Czene, K., Kere, J., Fredriksson, I., Bergh, J. C. S., & Hartman, J. (2014) · Breast Cancer Research · doi:10.1186/bcr3687 · Cited by 61
Jiang, X., Wang, C. Y., Fitch, S., & Yang, F. (2018) · Theranostics · doi:10.7150/thno.22736 · Cited by 59
Subacute (28 day) Toxicity of Surfactin C, a Lipopeptide Produced by Bacillus subtilis, in Rats
Hwang, Y., Kim, M.-S., Song, I.-B., Park, B.-K., Lim, J., Park, S., & Yun, H. (2009) · Eisei kagaku · doi:10.1248/jhs.55.351 · Cited by 58
Characterization of the Tumor-Microenvironment in Patient-Derived Cervix Xenografts (OCICx)
Chaudary, N., Pintilie, M., Schwock, J., Dhani, N. C., Clarke, B. A., Milosevic, M., Fyles, A., & Hill, R. P. (2012) · Cancers · doi:10.3390/cancers4030821 · Cited by 54
Yu, J., Chen, Y., Zhang, Y., Yao, X., Qian, C., Huang, J., Zhu, S., Jiang, X., Shen, Q., & Gu, Z. (2014) · Chemical Communications · doi:10.1039/c3cc49870k · Cited by 54
Zbáida, S., & Levine, W. G. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00019a011 · Cited by 53
Tercel, M., Atwell, G. J., Yang, S., Stevenson, R. J., Botting, K. J., Boyd, M., Smith, E., Anderson, R. F., Denny, W. A., Wilson, W. R., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901202b · Cited by 52
Chen, Y.-L., Yang, T., Chen, K., Wu, C., Hsu, S., & Hsueh, C. (2016) · Cellular Oncology · doi:10.1007/s13402-016-0285-5 · Cited by 50
Targeting hypoxia brings breath of fresh air to cancer therapy
Moyer, M. W. (2012) · Nature Medicine · doi:10.1038/nm0512-636b · Cited by 47
Zong, Z., Hua, L., Wang, Z., Xu, H., Ye, C., Pan, B., Zhao, Z., Zhang, L., Lu, J. L., Liu, H., et al. (2019) · Drug Delivery · doi:10.1080/10717544.2018.1534897 · Cited by 45
Nagao, S., Taguchi, K., Miyazaki, Y., Wakayama, T., Chuang, V. T. G., Yamasaki, K., Watanabe, H., Sakai, H., Otagiri, M., & Maruyama, T. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.016 · Cited by 42
Adaptions to Hypoxia and Redox Stress: Essential Concepts Confounded by Misleading Terminology
Loscalzo, J. (2016) · Circulation Research · doi:10.1161/circresaha.116.309394 · Cited by 42
Hypoxia-responsive drug–drug conjugated nanoparticles for breast cancer synergistic therapy
Zhang, R., Li, Y., Zhang, M., Tang, Q., & Zhang, X. (2016) · RSC Advances · doi:10.1039/c6ra01560c · Cited by 39
Abbattista, M. R., Jamieson, S. M. F., Gu, Y., Nickel, J. E., Pullen, S. M., Patterson, A. V., Wilson, W. R., & Guise, C. P. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1017171 · Cited by 37
Sambath, K., Jana, A., Selvakumar, M., Venkatesh, Y., Paul, A., Shah, S. S., & Singh, N. D. P. (2017) · Journal of Materials Chemistry B · doi:10.1039/c6tb02944b · Cited by 35
Hypoxia-Responsive Mesoporous Nanoparticles for Doxorubicin Delivery
Khatoon, S., Han, H. S., Jeon, J., Rao, N. V., Jeong, D.-W., Ikram, M., Yasin, T., Yi, G., & Park, J. H. (2018) · Polymers · doi:10.3390/polym10040390 · Cited by 33
McIntosh, D. P., Cooke, R. J., McLachlan, A. J., Daley‐Yates, P. T., & Rowland, M. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960282u · Cited by 32
Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy
Khatoon, S., Han, H. S., Lee, M., Lee, H., Jung, D.-W., Thambi, T., Ikram, M., Kang, Y. M., Yi, G., & Park, J. H. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.04.011 · Cited by 32
Brownlee, W. J., & Seib, F. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-30517-3 · Cited by 31
A novel “mosaic-type” nanoparticle for selective drug release targeting hypoxic cancer cells
Wang, W., Li, X., Wang, Z., Zhang, J., Dong, X., Wu, Y., Fang, C., Zhou, A., & Wu, Y. (2018) · Nanoscale · doi:10.1039/c8nr06452k · Cited by 26
Mu, J., Meng, X., Chen, L., Lu, Z., Mou, Q., Li, X., Wang, S., & Yue, H. (2017) · RSC Advances · doi:10.1039/c6ra28161c · Cited by 22
Luminescent Probe Based Techniques for Hypoxia Imaging
Jaworski, J. W. (2017) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2017.06.00160 · Cited by 21
Sundfør, K., Lyng, H., & Rofstad, E. K. (1998) · Acta Oncologica · doi:10.1080/028418698430016 · Cited by 15
How Can We fine-tune Nanoparticles to Improve Drug delivery?
Li, Z. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0031 · Cited by 15
Nanotechnology in Cancer Therapy: Overview and Applications
Choi, E. J. (2011) · Journal of Pharmaceutical Investigation · doi:10.4333/kps.2011.41.2.059 · Cited by 7
Cited by
Conquering the Hypoxia Limitation for Photodynamic Therapy
Wan, Y., Fu, L., Li, C., Lin, J., & Huang, P. (2021) · Advanced Materials · doi:10.1002/adma.202103978 · Cited by 705
Gavilán, H., Avugadda, S. K., Fernández-Cabada, T., Soni, N., Cassani, M., Mai, B. T., Chantrell, R., & Pellegrino, T. (2021) · Chemical Society Reviews · doi:10.1039/d1cs00427a · Cited by 525
Moradi Kashkooli, F., Soltani, M., & Souri, M. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.08.012 · Cited by 514
Theranostic Fluorescent Probes
Sharma, A., Verwilst, P., Li, M., Ma, D., Singh, N., Yoo, J., Kim, Y., Yang, Y., Zhu, J.-H., Huang, H., et al. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00778 · Cited by 499
Tumor‐Microenvironment‐Responsive Nanomedicine for Enhanced Cancer Immunotherapy
Peng, S., Xiao, F., Chen, M., & Gao, H. (2022) · Advanced Science · doi:10.1002/advs.202103836 · Cited by 441
Metadata
- Authors
- Kumari, R., Sunil, D., & Ningthoujam, R. S.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-03
- Volume
- 319
- Pages
- 135-156
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2997383418
- Cited by
- 263
- References
- 226
- FWCI
- 7.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.